A. Petzold
Nature Reviews Neurology · 2005–2022
A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from A. Petzold's perspective
Ordered by how strongly the researchers A. Petzold trusts endorse each paper. Same corpus, a different order for every researcher.
- GFAP in health and disease. (Progress in neurobiology)
- Amyotrophic lateral sclerosis. (Current Opinion in Neurology)
- Minocycline Provides Neuroprotection Against N-Methyl-d-aspartate Neurotoxicity by Inhibiting Microglia1 (Journal of Immunology)
- Neuronal Intermediate Filaments
- Inflammation and Alzheimer's disease. (Neurobiology of Aging)
- Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease (Nature Medicine)
- Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. (New England Journal of Medicine)
- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. (Journal of the American Medical Association (JAMA))
- Hematologic parameters in patients with COVID‐19 infection (American journal of hematology/oncology)
- To Err is Human: Building a Safer Health System
Their papers
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking (2009) — 793 citations
- Blood GFAP as an emerging biomarker in brain and spinal cord disorders (2022) — 651 citations
- Neurofilaments as biomarkers in neurological disorders (2018) — 1,788 citations
- The APOSTEL recommendations for reporting quantitative optical coherence tomography studies (2016) — 387 citations
- Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. (2005) — 684 citations